Figure - available from: Frontiers in Immunology
This content is subject to copyright.
The impacts of nucleated cells from G-CSF-primed BM harvests on post-transplant outcomes in halpo-HSCT using G-CSF-primed BM and PBSCs mixture. The G-CSF-mobilized BM and PBSCs cohort was classified into two groups according to infused nucleated cells harvested from G-CSF-primed BM: 0.51-5.20×10⁸/kg (the black line, n=62), 5.20-16.30×10⁸/kg (the gray line, n=63). (A) relapse; (B) TRM; (C) Overall survival; (D) Disease-free survival.

The impacts of nucleated cells from G-CSF-primed BM harvests on post-transplant outcomes in halpo-HSCT using G-CSF-primed BM and PBSCs mixture. The G-CSF-mobilized BM and PBSCs cohort was classified into two groups according to infused nucleated cells harvested from G-CSF-primed BM: 0.51-5.20×10⁸/kg (the black line, n=62), 5.20-16.30×10⁸/kg (the gray line, n=63). (A) relapse; (B) TRM; (C) Overall survival; (D) Disease-free survival.

Source publication
Article
Full-text available
To determine the influence of graft composition in haplo-HSCT, we summarized the long-term consequences of 251 consecutive transplantations from haploidentical donors. For donor-recipient HLA3/6-matched setting, 125 cases used G-CSF-mobilized BM and PBSCs mixtures, while 126 cases only used G-CSF-mobilized PBSCs in HLA4/6-matched transplantation. O...